Abhijit Gadkari, PhD

Executive Director, HEOR Therapeutic Area Head, Immunology & Neuroscience
Novartis Pharmaceuticals Corporation

Poster(s):

• (68) Healthcare resource utilization and costs in patients with multiple sclerosis treated with ofatumumab vs ocrelizumab
  Wednesday, October 29, 2025